# Adam D'Augelli

> Adam D'Augelli is a seed investor at HashiCorp (San Francisco) backing Biotechnology and Software. See 49 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [HashiCorp](https://shizune.co/investors/profile/hashicorp)
- Location: San Francisco, United States
- Total investments: 49
- Last investment: Oct 2024
- Lead investor: 37%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/adamdaugelli
- X (Twitter): http://twitter.com/adaugelli
- Website: https://x.com/adaugelli
- Facebook: https://www.facebook.com/adaugelli

Adam D'Augelli is a seed investor at HashiCorp in San Francisco focused on Biotechnology and Software. Adam is a partner at True Ventures. He previously worked with True portfolio company B-Stock, an online marketplace for liquidating excess inventory, and initially joined the True Ventures team as an analyst in 2010.Adam graduated magna cum laude from the University of Florida with a bachelor’s degree in science and a master’s degree in finance.As an undergraduate, he launched and ran an independent, donation-based record label and later created “Digital Frontiers,” a course exploring how the internet and technology are changing the global business landscape, which he taught at the University of Florida. He shares his thoughts on his blog, Life in Beta.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 12% |
| Software | 5 | 10% |
| Medical | 3 | 6% |
| Blockchain | 3 | 6% |
| Health Care | 3 | 6% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 14 | 29% |
| Series A | 10 | 20% |
| Series B | 7 | 14% |
| Series C | 5 | 10% |
| Funding Round | 4 | 8% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 13 | 27% |
| Canada | 2 | 4% |
| Singapore | 2 | 4% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| RadiantGraph | RadiantGraph is on a mission to make healthcare more accessible and user-friendly for all of us. AI technology assists top healthcare organizations in developing deeper and more meaningful connections with their patients, resulting in tailored engagement and therapeutic outcomes. | $11M | Series A | Oct 10, 2024 |  |
| RadiantGraph | RadiantGraph is on a mission to make healthcare more accessible and user-friendly for all of us. AI technology assists top healthcare organizations in developing deeper and more meaningful connections with their patients, resulting in tailored engagement and therapeutic outcomes. | $5M | Seed | Oct 25, 2023 |  |
| Deduce | Deduce protects businesses and their customers from unauthorized account access, data leakage, and identity fraud. We eliminate fraud in real-time using risk algorithms and behavioral analytics across the most comprehensive network of consumer identity data. This empowers any organization to harness the value of collective identity-based threatintelligence and cybersecurity. | $9M |  | Sep 13, 2023 |  |
| Deduce | Deduce protects businesses and their customers from unauthorized account access, data leakage, and identity fraud. We eliminate fraud in real-time using risk algorithms and behavioral analytics across the most comprehensive network of consumer identity data. This empowers any organization to harness the value of collective identity-based threatintelligence and cybersecurity. | $9M | Series B | Sep 13, 2023 |  |
| Fork & Good | Fork & Good is a food company developing a new approach to growing food. It creates pure animal proteins and fats that are clean, traceable, and delicious. It was founded in 2018 and is based in Brooklyn, New York. |  | Venture - Series Unknown | Mar 14, 2023 |  |
| Flipside Crypto | Flipside Crypto provides unparalleled analytics and business intelligence to crypto organizations.Their suite of analytics tools provides insights into user behaviors, developer activities, and financial activities, as well as FCAS, a relative value for measuring the fundamental health of cryptocurrency projects. It provides analytics tocryptocurrency organizations and distributes FCAS via partners such as CoinMarketCap, Messari, MarketWatch, and TheStreet. Flipside Crypto is backed by CoinBase Ventures, True Ventures, Founder Collective, Digital Currency Group, and other investors.Dave Balter, Eric Stone, and Jim Myers established it in Boston, Massachusetts in 2017. | $50M | Series A | Apr 19, 2022 |  |
| Kettle | Kettle is a machine-learning powered reinsurer balancing risk in a changing climate. It's proprietary deep learning algorithms use more than seven billion lines of a satellite, weather, and ground truth data. These models use Swarm Neural Networks to find patterns that enable more accurate predictions, thereby reducing loss ratios. Kettle isstructured to sell reinsurance to insurers. | $25M | Series A | Nov 18, 2021 |  |
| InterVenn | InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM signals found in human blood and tissue for biomarker and target discovery. It specializes in the fields of biotechnology and life science. The company's VISTA is the first commercially available platform that can assess (serum orplasma) protein glycosylation in a site-specific manner, across thousands of peptides and glycopeptides.It was founded in 2017 and headquartered in Redwood City, California. | $201M | Series C | Aug 02, 2021 |  |
| Biconomy | Biconomy is a relayer infrastructure network and transaction highway to reduce the friction between applications built on the blockchain and the end-users. Biconomy’s relayer network comprises of an SDK and dashboard that abstracts and hides many of the complexities of opening a wallet, storing private keys, paying gas, and buying cryptocurrency. | $9M | Seed | Jul 28, 2021 |  |
| Deep Genomics | Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI. | $180M | Series C | Jul 28, 2021 |  |

10 of 49 investments shown.

## Co-investors
- [Lerer Hippeau](https://shizune.co/investors/profile/lerer-ventures) — VC Fund, 7 deals together
- [Matrix](https://shizune.co/investors/profile/matrix-partners) — VC Fund, 6 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 5 deals together
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund, 5 deals together
- [Bullpen Capital](https://shizune.co/investors/profile/bullpen-capital) — VC Fund, 4 deals together
- [Collaborative Fund](https://shizune.co/investors/profile/collaborative-fund) — VC Fund, 4 deals together

## About HashiCorp

VC Fund · San Francisco, United States

HashiCorp is an open-source software company based in San Francisco, California. HashiCorp provides open source tools and commercial products that enable developers, operators, and security professionals to provide secure and run distributed application infrastructure. It was founded in 2012 by Mitchell Hashimoto and Armon Dadgar.HashiCorp offersboth open source and paid commercial products.

5 contacts available at HashiCorp.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Manoske | Principal Product Manager - Cryptography and Security Products | https://shizune.co/investors/profile/andrew-manoske |
| Dave McJannet | CEO | https://shizune.co/investors/profile/dave-mcjannet-6ccf |
| Adam D'Augelli | Investor | https://shizune.co/investors/profile/adam-daugelli |
| Burzin Patel | VP, Worldwide Alliances | https://shizune.co/investors/profile/burzin-patel |
| David McJannet | CEO | https://shizune.co/investors/profile/david-mcjannet |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Adam D'Augelli invest in?

Adam D'Augelli invests primarily in Biotechnology, Software and Medical startups, most often at Seed and Series A stage. Most of the 49 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Adam D'Augelli last invest?

The most recent investment recorded for Adam D'Augelli closed in Oct 2024. Shizune tracks 49 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co